HSGP is engaged closely with the USFDA and is committed to address the OAI observations through planned remediation measures
The inspection concluded with the issuance of a form 483 with five observations
Lupin's Pithampur Unit-1 gets Form 483 from USFDA with 3 observations
The net-zero target approval complements the company's near-term emission reduction targets
Agreement enables access of EU-approved treatment for myotonia symptoms in non-dystrophic myotonic disorders to patients from Argentina and Colombia
Enzalutamide Capsules will be produced at the Group’s manufacturing site at Moraiya, Ahmedabad
Potential of Ayurveda’s contribution in global health system through various innovative practices
The Shasta system and Shasta Whole-Genome Amplification (WGA) Kit dramatically increase throughput for WGA by processing up to 1,500 cells per run
Subscribe To Our Newsletter & Stay Updated
